Fig. 2

Gross histological tissues results surrounding implanted CNTY and control Pt–Ir electrodes at week 1 and 12 (×100). a HE staining of tissues around CNTY electrode at 1 week; b NeuNimmunostaining of tissues around CNTY electrode at 1 week; c CD68 immunostaining of tissues around CNTY electrode at 1 week; d GFAP immunostaining of tissues around CNTY electrode at 1 week; e HE staining of tissues around Pt–Ir electrode at 1 week; f NeuNimmunostaining of tissues around Pt–Ir electrode at 1 week; g CD68 immunostaining of tissues around Pt–Ir electrode at 1 week; h GFAP immunostaining of tissues around Pt–Ir electrode at 1 week; i HE staining of tissues around CNTY electrode at 12 weeks; j NeuNimmunostaining of tissues around CNTY electrode at 12 weeks; k CD68 immunostaining of tissues around CNTY electrode at 12 weeks; l GFAP immunostaining of tissues around CNTY electrode at 12 weeks; m HE staining of tissues around Pt–Ir electrode at 12 weeks; n NeuNimmunostaining of tissues around Pt–Ir electrode at 12 weeks; o CD68 immunostaining of tissues around Pt–Ir electrode at 12 weeks; p GFAP immunostaining of tissues around Pt–Ir electrode at 12 weeks